Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Johnson and Johnson
Moodys
Harvard Business School
Merck

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Drug Price Trends for METRONIDAZOLE

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for METRONIDAZOLE

Average Pharmacy Cost for METRONIDAZOLE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
METRONIDAZOLE 250 MG TABLET 69292-0207-50 0.16799 EACH 2019-11-06
METRONIDAZOLE 500 MG TABLET 72578-0008-18 0.19230 EACH 2019-10-23
METRONIDAZOLE 500 MG TABLET 72578-0008-05 0.19230 EACH 2019-10-23
METRONIDAZOLE 500 MG TABLET 72578-0008-01 0.19230 EACH 2019-10-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for METRONIDAZOLE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
VANDAZOLE 0.75% GEL,VAG Upsher-Smith Laboratories, LLC 00245-0860-70 70GM 30.15 0.43071 GM 2019-08-01 - 2024-07-31 FSS
METRONIDAZOLE 250MG TAB,UD Major Pharmaceuticals 00904-1453-61 100 31.01 0.31010 EACH 2018-12-01 - 2023-11-30 FSS
METRONIDAZOLE 500MG TAB Golden State Medical Supply, Inc. 51407-0014-01 100 39.83 0.39830 EACH 2018-10-19 - 2022-12-31 FSS
METRONIDAZOLE 500MG TAB Golden State Medical Supply, Inc. 51407-0014-01 100 30.00 0.30000 EACH 2019-09-23 - 2022-12-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Medtronic
Dow
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.